Query author contributions in Reactome

Reactome depends on collaboration between our curation team and outside experts to assemble and peer-review its pathway modules. The integration of ORCID within Reactome enables us to meet a key challenge with authoring, curating and reviewing biological information by incentivizing and crediting the external experts that contribute their expertise and time to the Reactome curation process. More information is available at ORCID and Reactome.

If you have an ORCID ID that is not listed on this page, please forward this information to us and we will update your Reactome pathway records.

Details on Person Jassal, Bijay, 2021-04-21

Class:Id	InstanceEdit:9728508
_displayName	Jassal, Bijay, 2021-04-21
_timestamp	2021-04-21 10:11:02
author	[Person:73447] Jassal, Bijay
dateTime	2021-04-21 10:09:51
(created)	[Person:9728481] Bělohlávek, Jan [Person:9728482] Katsuno, Kenji [Person:9728483] Yokota, Masayuki [Person:9728484] Petrie, Mark C [Person:9728485] DeMets, David L [Person:9728486] Vinh, Pham N [LiteratureReference:9728487] Dapagliflozin in Patients with Heart Failure and Reduced Ejection Fraction [Person:9728488] Anand, Inder S [Person:9728489] Schou, Morten [Person:9728490] Fujimori, Yoshikazu List all 67 refering instances
(modified)	[ChemicalDrug:9728119] ipragliflozin [extracellular region] [ChemicalDrug:9728138] empagliflozin [extracellular region] [Reaction:9728150] SLC5A2 binds gliflozins [Homo sapiens] [ChemicalDrug:9728168] dapagliflozin [extracellular region] [ChemicalDrug:9728173] sotagliflozin [extracellular region] [ChemicalDrug:9728190] tofogliflozin [extracellular region] [ChemicalDrug:9728209] ertugliflozin [extracellular region] [ChemicalDrug:9728221] canagliflozin [extracellular region]
[Change default viewing format]

No pathways have been reviewed or authored by Jassal, Bijay, 2021-04-21 (9728508)